Similarly, studies have also reported the tumor-promoting role of IGF2BP1, IGF2BP3, IGFBP6 and IGFL2 in several cancers such as hepatocellular carcinoma, pancreatic and prostate cancers [37–40]. This evidence concerns the gene IGF2BP3 and neoplasm.